NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Operating Income (2010 - 2026)

NextPlat's (NXPL) quarterly Operating Income came in at -$127000.0 in Q2 2026, up 93.06% year-over-year from -$65783.9 in Q2 2025, and up 88.49% quarter-over-quarter from -$1.1 million in Q1 2026.

Analysis

NextPlat (NXPL) Operating Income (2010 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Operating Income for 16 consecutive years, with -$127000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Operating Income rose 93.06% year-over-year to -$127000.0 in Q2 2026; TTM through Jun 2026 was -$6.9 million, a 51.3% increase from a year earlier, with the FY2025 full-year figure at -$9.0 million, up 60.91% from the prior year.
  • Operating Income was -$127000.0 for Q2 2026 at NextPlat, up from -$1.1 million in the prior quarter.
  • Over five years, Operating Income peaked at -$127000.0 in Q2 2026 and troughed at -$15.2 million in Q4 2023.
  • A 5-year average of -$3.6 million and a median of -$2.1 million in 2022 frame the typical range for Operating Income.
  • Across the five-year window, Operating Income plunged 467.6% in 2023 and soared 93.06% in 2026, its largest moves.
  • Over 5 years, Operating Income stood at -$2.7 million in 2022, then sank by 467.6% to -$15.2 million in 2023, then jumped by 84.9% to -$2.3 million in 2024, then sank by 61.58% to -$3.7 million in 2025, then soared by 96.56% to -$127000.0 in 2026.
  • The last three Operating Income figures came in at -$127000.0 (Q2 2026), -$1.1 million (Q1 2026), and -$3.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn -231.00 Mn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 6.30 Mn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 39.97 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 129.77 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 740.00 Mn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 40.46 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -73.42 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 39.73 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 1.74 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn -127,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -127,000.00
Mar 31, 2026 -1.10 Mn
Dec 31, 2025 -3.70 Mn
Sep 30, 2025 -1.99 Mn
Jun 30, 2025 -1.83 Mn
Mar 31, 2025 -2.08 Mn
Dec 31, 2024 -2.29 Mn
Sep 30, 2024 -8.00 Mn
Jun 30, 2024 -10.90 Mn
Mar 31, 2024 -1.84 Mn
Dec 31, 2023 -15.16 Mn
Sep 30, 2023 -3.48 Mn
Jun 30, 2023 -3.36 Mn
Mar 31, 2023 -1.24 Mn
Dec 31, 2022 -2.67 Mn
Sep 30, 2022 -2.16 Mn
Jun 30, 2022 -1.53 Mn
Mar 31, 2022 -834,615.00
Dec 31, 2021 -3.54 Mn
Sep 30, 2021 -2.24 Mn